AU2002327506A1 - Folded monomers of the hiv-1 protease and methods of their use - Google Patents

Folded monomers of the hiv-1 protease and methods of their use

Info

Publication number
AU2002327506A1
AU2002327506A1 AU2002327506A AU2002327506A AU2002327506A1 AU 2002327506 A1 AU2002327506 A1 AU 2002327506A1 AU 2002327506 A AU2002327506 A AU 2002327506A AU 2002327506 A AU2002327506 A AU 2002327506A AU 2002327506 A1 AU2002327506 A1 AU 2002327506A1
Authority
AU
Australia
Prior art keywords
hiv
protease
methods
folded monomers
monomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002327506A
Inventor
Angela M. Gronenborn
Rieko Ishima
John L. Medabalimi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOVERNMENT OF United States, HEALT, Secretary of, Department of
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002327506A1 publication Critical patent/AU2002327506A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002327506A 2001-08-23 2002-08-23 Folded monomers of the hiv-1 protease and methods of their use Abandoned AU2002327506A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31438801P 2001-08-23 2001-08-23
US60/314,388 2001-08-23
PCT/US2002/026757 WO2003017934A2 (en) 2001-08-23 2002-08-23 Folded monomers of the hiv-1 protease and methods of their use

Publications (1)

Publication Number Publication Date
AU2002327506A1 true AU2002327506A1 (en) 2003-03-10

Family

ID=23219758

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002327506A Abandoned AU2002327506A1 (en) 2001-08-23 2002-08-23 Folded monomers of the hiv-1 protease and methods of their use

Country Status (2)

Country Link
AU (1) AU2002327506A1 (en)
WO (1) WO2003017934A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165794A (en) * 1994-11-10 2000-12-26 The Regents Of The University Of California Suppression of proteolytic activity by dysfunctional protease formation

Also Published As

Publication number Publication date
WO2003017934A3 (en) 2003-12-24
WO2003017934A2 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002314466A1 (en) Withasol and methods of use
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
AU2002359512A1 (en) Belts and methods of use thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2002343724A1 (en) Adhesive and use thereof
AU2002310237A1 (en) Sponge-derived terpenoids and methods of use
AU2002343042A1 (en) Virulence proteins of the genus yersinia and uses thereof
AU2002302247A1 (en) Genes and proteins involved in the biosynthesis of enediyne ring structures
AU2002327506A1 (en) Folded monomers of the hiv-1 protease and methods of their use
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001225523A1 (en) Novel arylpropionaldehyde derivatives and production and use of the same
AUPR595601A0 (en) Hypoglycaemic peptides and methods of use thereof
AU2002326718A1 (en) Tramdorins and methods of using tramdorins
AUPR589701A0 (en) Novel peptide and use thereof
AU2002258842A1 (en) Hydrogenfluorides of aminosilanols and their use
AU2002304858A1 (en) Ophthalmic compositions and use thereof
AU2002333371A1 (en) Novel 4-aminofuropyrimidines and the use thereof
AU2002228426A1 (en) Neurotonin and use thereof
AU2002330299A1 (en) Antibody and use of the same
AU2002354188B2 (en) Novel peptides and medicinal uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase